Logo for Cara Therapeutics Inc

Cara Therapeutics Investor Relations Material

Latest events

Logo for Cara Therapeutics Inc

M&A Announcement

Cara Therapeutics
Logo for Cara Therapeutics

M&A Announcement

18 Dec, 2024
Logo for Cara Therapeutics

Q3 2024

14 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Cara Therapeutics Inc

Access all reports
Cara Therapeutics, Inc. is a biopharmaceutical company that focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States.